Result: Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia

*Title*:

Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia / M. Scherr, A. Elder, K. Battmer, D. Barzan, S. Bomken, M. Ricke-Hoch, A. Schröder, L. Venturini, H. J. Blair, J. Vormoor, O. Ottmann, A. Ganser, A. Pich, D. Hilfiker-Kleiner, O. Heidenreich and M. Eder

*Author/editor-in-chief*:

*Published in*:

Leukemia. - London : Springer Nature, 1997-. - Online-Ressource. - ISSN 1476-5551. - Band 28, Heft 3 (2014), Seite 554-565
*show_all_articles*

*Manufacture*:

2014

*Physical description scale*:

Online-Ressource

*Format*:

*eArticle*

*Language*:

*eng*

*DOI*:

10.1038/leu.2013.361

*Result*: Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia